152 related articles for article (PubMed ID: 38223482)
1. Effects of Thalidomide on Erythropoiesis and Iron Homeostasis in Transfusion-Dependent β-Thalassemia.
Yang K; Liu X; Peng W; Hua F; Li L; Chen K; Zhang J; Luo S; Li W; Ding Y; Chen J; Xiao J
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024001. PubMed ID: 38223482
[TBL] [Abstract][Full Text] [Related]
2. Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions.
Kalleda N; Flace A; Altermatt P; Ingoglia G; Doucerain C; Nyffenegger N; Dürrenberger F; Manolova V
Haematologica; 2023 Oct; 108(10):2703-2714. PubMed ID: 37165842
[TBL] [Abstract][Full Text] [Related]
3. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
[No Abstract] [Full Text] [Related]
4. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
5. Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.
Porter J; Taher A; Viprakasit V; Kattamis A; Coates TD; Garbowski M; Dürrenberger F; Manolova V; Richard F; Cappellini MD
Expert Rev Hematol; 2021 Jul; 14(7):633-644. PubMed ID: 34324404
[TBL] [Abstract][Full Text] [Related]
6. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
Pasricha SR; Frazer DM; Bowden DK; Anderson GJ
Blood; 2013 Jul; 122(1):124-33. PubMed ID: 23656728
[TBL] [Abstract][Full Text] [Related]
7. Iron Status in Newly Diagnosed
Susanah S; Rakhmilla LE; Ghozali M; Trisaputra JO; Moestopo O; Sribudiani Y; Idjradinata PS; Maskoen AM
Biomed Res Int; 2021; 2021():5560319. PubMed ID: 33954177
[TBL] [Abstract][Full Text] [Related]
8. Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia.
Garbowski MW; Ugidos M; Risueño A; Shetty JK; Schwickart M; Hermine O; Porter JB; Thakurta A; Vodala S
Am J Hematol; 2024 Feb; 99(2):182-192. PubMed ID: 37782758
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin and Anemia: A Tight Relationship.
Pagani A; Nai A; Silvestri L; Camaschella C
Front Physiol; 2019; 10():1294. PubMed ID: 31649559
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia.
Di Modica SM; Tanzi E; Olivari V; Lidonnici MR; Pettinato M; Pagani A; Tiboni F; Furiosi V; Silvestri L; Ferrari G; Rivella S; Nai A
Am J Hematol; 2022 Oct; 97(10):1324-1336. PubMed ID: 36071579
[TBL] [Abstract][Full Text] [Related]
11. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
Zaman BA; Rasool SO; Abdo JM
Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia.
Piga A; Longo F; Gamberini MR; Voskaridou E; Ricchi P; Caruso V; Pietrangelo A; Zhang X; Shetty JK; Attie KM; Tartaglione I
Ther Adv Hematol; 2022; 13():20406207221134404. PubMed ID: 36505885
[TBL] [Abstract][Full Text] [Related]
13. Altered erythropoiesis and iron metabolism in carriers of thalassemia.
Guimarães JS; Cominal JG; Silva-Pinto AC; Olbina G; Ginzburg YZ; Nandi V; Westerman M; Rivella S; de Souza AM
Eur J Haematol; 2015 Jun; 94(6):511-8. PubMed ID: 25307880
[TBL] [Abstract][Full Text] [Related]
14. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major.
Kattamis A; Papassotiriou I; Palaiologou D; Apostolakou F; Galani A; Ladis V; Sakellaropoulos N; Papanikolaou G
Haematologica; 2006 Jun; 91(6):809-12. PubMed ID: 16769583
[TBL] [Abstract][Full Text] [Related]
15. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
[TBL] [Abstract][Full Text] [Related]
16. Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits.
Sulovska L; Holub D; Zidova Z; Divoka M; Hajduch M; Mihal V; Vrbkova J; Horvathova M; Pospisilova D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):231-7. PubMed ID: 26592557
[TBL] [Abstract][Full Text] [Related]
17. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
[TBL] [Abstract][Full Text] [Related]
18. Correlation of hepcidin and serum ferritin levels in thalassemia patients at Chiang Mai University Hospital.
Tantiworawit A; Khemakapasiddhi S; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Charoenkwan P; Srichairatanakool S; Fanhchaksai K
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33565577
[TBL] [Abstract][Full Text] [Related]
19. New therapeutic targets in transfusion-dependent and -independent thalassemia.
Cappellini MD; Motta I
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
[TBL] [Abstract][Full Text] [Related]
20. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.
Jones E; Pasricha SR; Allen A; Evans P; Fisher CA; Wray K; Premawardhena A; Bandara D; Perera A; Webster C; Sturges P; Olivieri NF; St Pierre T; Armitage AE; Porter JB; Weatherall DJ; Drakesmith H
Blood; 2015 Jan; 125(5):873-80. PubMed ID: 25519750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
